| pubmed-article:1905534 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0227525 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0003695 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C1367441 | lld:lifeskim |
| pubmed-article:1905534 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:1905534 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1905534 | pubmed:dateCreated | 1991-7-31 | lld:pubmed |
| pubmed-article:1905534 | pubmed:abstractText | Rat hepatocytes were maintained in a serum-free, hormonally defined medium supplemented with 50-500 microM albumin-bound 20:1 (n-9) vs 20:4 (n-6). The induction of fatty acid synthase mRNA by a mix of insulin/dexamethasone/T3 was inhibited in a dose dependent fashion by 20:4 (n-6). The abundance of beta-actin mRNA was not suppressed by 20:4 (n-6). The expression of fatty acid synthase was actually stimulated 2-fold by 20:1 (n-9). It would appear that the in vivo inhibition of fatty acid synthase gene expression by dietary polyunsaturated fatty acids is a specific hepatocelluar event. | lld:pubmed |
| pubmed-article:1905534 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1905534 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1905534 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1905534 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:1905534 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:1905534 | pubmed:author | pubmed-author:ClarkeS DSD | lld:pubmed |
| pubmed-article:1905534 | pubmed:author | pubmed-author:ArmstrongM... | lld:pubmed |
| pubmed-article:1905534 | pubmed:author | pubmed-author:BlakeW LWL | lld:pubmed |
| pubmed-article:1905534 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1905534 | pubmed:day | 28 | lld:pubmed |
| pubmed-article:1905534 | pubmed:volume | 177 | lld:pubmed |
| pubmed-article:1905534 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1905534 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1905534 | pubmed:pagination | 1056-61 | lld:pubmed |
| pubmed-article:1905534 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:meshHeading | pubmed-meshheading:1905534-... | lld:pubmed |
| pubmed-article:1905534 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1905534 | pubmed:articleTitle | Arachidonic acid suppression of fatty acid synthase gene expression in cultured rat hepatocytes. | lld:pubmed |
| pubmed-article:1905534 | pubmed:affiliation | Unit of Performance Enhancement, Upjohn Company, Kalamazoo, MI 49001. | lld:pubmed |
| pubmed-article:1905534 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1905534 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1905534 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1905534 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1905534 | lld:pubmed |
